We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4.
Journal of Biological Chemistry 2018 Februrary 24
The a subunit is the largest of 15 different subunits that make up the vacuolar H+ -ATPase (V-ATPase) complex, where it functions in proton translocation. In mammals, this subunit has four paralogous isoforms, a 1- a 4, which may encode signals for targeting assembled V-ATPases to specific intracellular locations. Despite the functional importance of the a subunit, its structure remains controversial. By studying molecular mechanisms of human disease-causing missense mutations within a subunit isoforms, we may identify domains critical for V-ATPase targeting, activity and/or regulation. cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 ( a 2) and ATP6V0A4 ( a 4) subunits and their mutants, a 2P405L (causing cutis laxa), and a 4R449H and a 4G820R (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells. N -Glycosylation was assessed using endoglycosidases, revealing that a 2P405L , a 4R449H , and a 4G820R were fully N -glycosylated. Cycloheximide (CHX) chase assays revealed that a 2P405L and a 4R449H were unstable relative to wildtype. a 4R449H was degraded predominantly in the proteasomal pathway, whereas a 2P405L was degraded in both proteasomal and lysosomal pathways. Immunofluorescence studies disclosed retention in the endoplasmic reticulum and defective cell-surface expression of a 4R449H and defective Golgi trafficking of a 2P405L Co-immunoprecipitation studies revealed an increase in association of a 4R449H with the V 0 assembly factor VMA21, and a reduced association with the V 1 sector subunit, ATP6V1B1 (B1). For a 4G820R , where stability, degradation, and trafficking were relatively unaffected, 3D molecular modeling suggested that the mutation causes dRTA by blocking the proton pathway. This study provides critical information that may assist rational drug design to manage dRTA and cutis laxa.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app